Search
for
Sort by
Research 331–360 of 1000+
- Guidelines based management of androgenetic alopecia
- Feature-Based Molecular Networks Identification of Bioactive Metabolites from Three Plants of the Polynesian Cosmetopoeia Targeting the Dermal Papilla Cells of the Hair Cycle
- Dihydrotestosterone and 5α-Reductase
- Comprehensive analysis of minoxidil effectiveness for hair growth
- Consensus position statement on emerging treatments in dermatology by the Association of Cutaneous Surgeons of India Task Force
- Androgenetic Alopecia: A Review
- Alopecias
- POST-FINASTERIDE SYNDROME AND POST-SSRI SEXUAL DYSFUNCTION: TWO CLINICAL CONDITIONS APPARENTLY DISTANT, BUT VERY CLOSE
- Pharmacogenetics of the Androgen Metabolic Pathway
- Tissue Regeneration, Stem Cells, and Wound Healing
- Finasteride and Dutasteride in the Treatment of Androgenetic Alopecia: Risk or Benefit?
- Drug Repurposing Patent Applications July–September 2025
- Is dehydroepiandrosterone a hormone?
- FINASTERIDE IN MODERN MEDICINE: THERAPEUTIC APPLICATIONS AND SYSTEMIC HEALTH IMPLICATIONS
- Antiandrogen therapy for androgenetic alopecia
- Chapter 14 Principles of drug metabolism
- Aldesleukin
- Steroid Hormones of Reproduction and Sexual Development
- Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor
- Role of 5 alpha-reductase inhibitors in the management of prostate cancer
- Post-finasteride syndrome
- 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia
- Clinical use of 5α-reductase inhibitors
- Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies
- Alopecia: managing the basics
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Expanding the therapeutic landscape of minoxidil for androgenetic alopecia: topical, oral and sublingual formulations
- Comparative efficacy of oral dutasteride and low-, medium-, and high-dose oral minoxidil: a six-month prospective trichoscopic and clinical study
- Burden of immune-related skin diseases worldwide, 1991–2021: insights and prediction from the Global Burden of Disease Study
- Finasteride